scholarly journals Thoracic Endovascular Aortic Repair in Patients with Prior Open Aortic Surgery

2013 ◽  
Vol 6 (1) ◽  
pp. 80-83 ◽  
Author(s):  
Hideyuki Shimizu ◽  
Akihiro Yoshitake ◽  
Satoshi Kawaguchi ◽  
Shinji Kawaguchi ◽  
Hidenobu Takaki ◽  
...  
Keyword(s):  
Aortic Surgery ◽  
Thoracic Endovascular Aortic Repair ◽  
Endovascular Aortic Repair ◽  
Aortic Repair

Open aortic surgery after thoracic endovascular aortic repair

2016 ◽  
Vol 64 (8) ◽  
pp. 441-449 ◽  
Author(s):  
Joseph S. Coselli ◽  
Konstantinos Spiliotopoulos ◽  
Ourania Preventza ◽  
Kim I. de la Cruz ◽  
Hiruni Amarasekara ◽  
...  
Keyword(s):  
Aortic Surgery ◽  
Thoracic Endovascular Aortic Repair ◽  
Endovascular Aortic Repair ◽  
Aortic Repair

scholarly journals Thoracic endovascular aortic repair for aortobronchial fistula: a case series

2020 ◽  
Author(s):  
Rajesh Vijayvergiya ◽  
Ganesh Kasinadhuni ◽  
Pruthvi C Revaiah ◽  
Anupam Lal ◽  
Ashish Sharma ◽  
...  
Keyword(s):  
Effective Treatment ◽  
Aortic Surgery ◽  
Thoracic Endovascular Aortic Repair ◽  
Endovascular Aortic Repair ◽  
Fistula Formation ◽  
Less Invasive ◽  
Post Surgery ◽  
Aortobronchial Fistula ◽  
Aortic Repair ◽  
Massive Haemoptysis

Abstract Background Aortobronchial fistula (ABF) formation following the rupture of thoracic pseudoaneurysm is a rare clinical entity. Its aetiology includes atherosclerosis, infections, trauma, post-surgery, and post-endovascular aortic repair. The clinical presentation of ABF includes intermittent or massive haemoptysis, acute respiratory distress, hypotension, and even death. These patients require an emergency aortic intervention to stop active haemorrhage. Thoracic endovascular aortic repair (TEVAR) is a less invasive, safe, and effective treatment compared to conventional open surgical repair Case summary We hereby report three cases of ruptured descending thoracic aortic pseudoaneurysms resulting in a fistula formation. The first two cases had tuberculosis as their underlying aetiology, while the third case was the result of previous open post-aortic surgery. All patients presented with massive haemoptysis and were successfully treated by emergency TEVAR and had favourable outcomes. Discussion Thoracic endovascular aortic repair is a rapid, less invasive, and effective treatment for emergency management of ABF. It has more than 85% technical success rates in the reported literature. We had procedural success in all three cases. The short and midterm outcome of ABF following TEVAR is favourable and encouraging.

scholarly journals S-100β and Antioxidant Capacity in Cerebrospinal Fluid during and after Thoracic Endovascular Aortic Repair

2017 ◽  
Vol 2017 ◽  
pp. 1-4
Author(s):  
Koichiro Nandate ◽  
Deepak Sharma ◽  
Hernando Olivar ◽  
Matthew Hallman ◽  
Ramesh Ramaiah ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Antioxidant Capacity ◽  
Aortic Surgery ◽  
Thoracic Endovascular Aortic Repair ◽  
Central Nervous System Injury ◽  
Endovascular Aortic Repair ◽  
Neurologic Complication ◽  
Aortic Repair ◽  
S 100

Background. Thoracic Endovascular Aortic Repair (TEVAR) has substantially decreased the mortality and major complications from aortic surgery. However, neurological complications such as spinal cord ischemia may still occur after TEVAR. S-100β is a biomarker of central nervous system injury, and oxidant injury plays an important role in neurological injury. In this pilot study, we examined the trends of S-100β and antioxidant capacity in the CSF during and after TEVAR. Methods. We recruited 10 patients who underwent elective TEVAR. CSF samples were collected through a lumbar catheter at the following time points: before the start of surgery (T0) and immediately (T1) and 24 (T2) and 48 hours (T3) after the deployment of the aortic stent. S-100β and CSF antioxidant capacity were analyzed with the use of commercially available kits. Results. We observed that the level of S-100β in all of the subjects at 24 hours after the deployment of the aortic stent (T2) increased. However, the levels of S-100β at T1 and T3 were comparable to the baseline value. The antioxidant capacity remained unchanged. No patient had a clinical neurologic complication. Conclusions. Our observations may indicate biochemical/subclinical central nervous system injury attributable to the deployment of the aortic stent.

Hypogastric Artery Stenting for Chronic Intermittent Spinal Cord Ischemia After Thoracic Endovascular Aortic Repair

2020 ◽  
Vol 27 (5) ◽  
pp. 801-804
Author(s):  
Catharina Gronert ◽  
Nikolaos Tsilimparis ◽  
Giuseppe Panuccio ◽  
Ahmed Eleshra ◽  
Fiona Rohlffs ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Ischemia ◽  
Thoracic Endovascular Aortic Repair ◽  
Neurological Symptoms ◽  
Endovascular Aortic Repair ◽  
Hypogastric Artery ◽  
Lower Extremity Weakness ◽  
Aortic Repair ◽  
The Right

Purpose: To report a case of chronic intermittent spinal cord ischemia (SCI) after thoracic endovascular aortic repair (TEVAR) and its successful treatment using hypogastric artery stenting. Case Report: A 79-year-old patient presented in May 2013 with a thoracic aortic aneurysm (TAA) and a contained rupture. He urgently underwent TEVAR that covered 274 mm of descending thoracic aorta without immediate postoperative signs of acute SCI. At 3-month follow-up, he reported repeating incidents of sudden lower extremity weakness leading to a fall with a humerus fracture. A neurological consultation revealed the tentative diagnosis of intermittent SCI caused by TEVAR and initially recommended a conservative approach. During the following year there was no clinical improvement of the symptoms. Computed tomography angiography showed a high-grade stenosis of the right hypogastric artery, which was stented in November 2014 to improve the collateral network of spinal cord perfusion. Following treatment, the patient had no further neurological symptoms; at 32 months after the reintervention, the imaging follow-up documented a patent stent and continued exclusion of the TAA. Conclusion: Intermittent neurological symptoms after TEVAR should be suspected as chronic intermittent SCI. The improvement of collateral networks of the spinal cord by revascularization of the hypogastric artery is a viable treatment option.

Sign in / Sign up

Export Citation Format

Share Document